Is Epigral Ltd (EPIGRAL) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Epigral Ltd is a good quality company .

Is Epigral Ltd (EPIGRAL) undervalued or overvalued?

The key valuation ratios of Epigral Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Epigral Ltd (EPIGRAL) share price return in the past 10 years?

Data is not available for this company

Is Epigral Ltd (EPIGRAL) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Epigral Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Epigral Ltd (EPIGRAL)?

Company share prices are keep on changing according to the market conditions. The current trading price of Epigral Ltd (EPIGRAL) on 17-Apr-2026 16:59:59 at 16:59 is 1200.75.

What is the P/E ratio of Epigral?

The latest standalone P/E ratio of Epigral as of 17-Apr-2026 is 15.34.

What is the P/B ratio of Epigral Ltd (EPIGRAL)?

The latest standalone P/B ratio of Epigral Ltd (EPIGRAL) as of 17-Apr-2026 is 2.42.

What is the 52-week high and low of Epigral Ltd (EPIGRAL)?

The 52-week high of Epigral Ltd (EPIGRAL) is Rs. 2114.30 and the 52-week low is Rs. 806.20.

Epigral Ltd (EPIGRAL) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Epigral Ltd (EPIGRAL)
Brand: Epigral

Epigral Ltd (EPIGRAL) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 543332 NSE: EPIGRAL | Chemicals | Small Cap

Epigral Ltd (EPIGRAL)

BSE: 543332 NSE: EPIGRAL

Key Metrics

Market Cap

₹5,180 Cr.

P/E Ratio

15.34

Price to Book (P/B)

2.42

Price to Sales (P/S)

2.14

EV/EBITDA

9.64

Return on Capital Employed (ROCE)

25.22%

Current Price

₹1,200.8

Return on Equity (ROE)

22.59%

Return on Assets (ROA)

12.00%

Operating Profit Margin

27.9%

Net Profit Margin

13.99%

Gross Profit Margin

25%

Book Value per Share

₹495.9

Sales Growth (YoY)

32.19%

Sales Growth (3 Years)

18.03%

Operating Profit Growth (1 Year)

47.7%

Operating Profit Growth (3 Years)

11.73%

Net Profit Growth (1 Year)

82.18%

52-Week Low / High

₹806 / 2,114

Net Profit Growth (3 Years)

-75.84%

Dividend Yield

0.32%

Promoter Holding

68.83%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of Epigral Ltd?

Epigral Ltd revenue growth is 32.2% for FY-2025 , which is below its 5 year CAGR of 33.1% , indicating slower growth.

Q.1 Promoter shareholding and pledge status of Epigral Ltd?

Promoters hold 68.83% of the Epigral Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Epigral Ltd vs industry peers?

Epigral Ltd revenue CAGR is 33.10% , compared to the industry median CAGR of 7.7% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does Epigral Ltd belong to?

Epigral Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Chemicals segment.

Q.1 Stock return of Epigral Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of 3.71% based on the current price.

DeciZen - make an informed investing decision on Epigral

Based on:

Data

Overall Rating ⓘ
Login to view analysis.

1. Quality

2. Valuation

3. Price Trend

Epigral stock performance

Key Ratios

Is Epigral Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	22.3%	18.5%	37.9%	36.9%	15.9%	16.7%	29.4%	32.2%	17.5%	25.2%	-
Value Creation Index ⓘ	0.7	0.4	1.8	1.7	0.2	0.2	1.1	1.3	0.3	0.9	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	398	392	598	710	611	829	1,551	2,188	1,929	2,550	2,419
Sales YoY Gr.	-	-1.7%	52.6%	18.9%	-14.1%	35.7%	87.2%	41.1%	-11.8%	32.2%	-
Adj EPS ⓘ	9.5	9.3	22	43.5	26.7	24	60.4	84.1	46.3	80.6	78.3
YoY Gr.	-	-1.4%	135.2%	97.8%	-38.5%	-10.1%	151.3%	39.4%	-45%	74.1%	-
BVPS (₹) ⓘ	41.7	51.1	73.1	68.4	89.7	113.9	174.7	257.3	301.8	441.2	495.9
Adj Net Profit ⓘ	67	66.1	155	179	111	99.8	251	350	192	348	338
Cash Flow from Ops. ⓘ	123	138	225	261	165	229	284	626	398	441	-
Debt/CF from Ops. ⓘ	1.5	0.9	0.3	1.5	3.2	2.4	3.5	1.4	2.4	1.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	22.9%	33.1%	18%	32.2%
Adj EPS ⓘ	26.9%	24.7%	10.1%	74.1%
BVPSⓘ	30%	37.5%	36.2%	46.2%
Share Price	-	-	3.8%	-36.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	26	20.1	35.4	35.4	20.6	15.8	35.6	39	16.6	22	16.7
Op. Profit Mgn % ⓘ	37.4	36.8	42.7	43.9	31.8	31.5	32.9	31.5	25	27.9	23.6
Net Profit Mgn % ⓘ	16.8	16.9	26	25.2	18.2	12.1	16.2	16	10	13.6	14
Debt to Equity ⓘ	0.6	0.3	0.1	0.8	0.9	0.8	1.4	0.8	0.8	0.3	-
Working Cap Days ⓘ	81	81	75	79	84	77	75	69	87	85	53
Cash Conv. Cycle ⓘ	24	35	28	25	34	26	40	41	40	36	16

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	78.3	78.3
TTM Sales (₹ Cr.)	2,419	2,419
BVPS (₹) ⓘ	495.9	496.1
Reserves (₹ Cr.) ⓘ	2,096	2,097
P/BV ⓘ	2.42	2.42
PE ⓘ	15.34	15.33

From the Market
52 Week Low / High (₹)	806.20 / 2114.30
All Time Low / High (₹)	386.35 / 2408.35
Market Cap (₹ Cr.)	5,180
Equity (₹ Cr.)	43.1
Face Value (₹)	10
Industry PE ⓘ	45.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Epigral - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	398	392	598	710	611	829	1,551	2,188	1,929	2,550
Operating Expenses ⓘ +	249	247	342	399	416	567	1,041	1,499	1,448	1,839
Manufacturing Costs	40	40	48	38	52	70	163	234	227	274
Material Costs	180	173	238	255	275	385	761	1,115	1,061	1,353
Employee Cost	12	14	16	21	33	41	52	69	81	98
Other Costs ⓘ	17	21	40	83	57	71	65	82	79	114
Operating Profit ⓘ	149	144	255	312	194	261	509	689	481	711
Operating Profit Margin (%)	37.4%	36.8%	42.7%	43.9%	31.8%	31.5%	32.9%	31.5%	24.9%	27.9%
Other Income ⓘ +	2	1	4	14	9	7	8	9	7	15
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	19	14	9	30	17	34	48	67	73	53
Depreciation ⓘ	44	55	55	54	44	74	86	109	124	133
Profit Before Tax ⓘ	88	75	195	242	141	161	383	523	291	540
Tax ⓘ	21	9	40	59	29	60	131	169	95	183
Profit After Tax	67	67	155	183	112	101	253	353	196	357
PAT Margin (%)	16.9%	17.0%	26.0%	25.7%	18.4%	12.2%	16.3%	16.2%	10.2%	14.0%
Adjusted EPS (₹)	9.5	9.4	22.0	44.4	27.0	24.3	60.8	85.0	47.1	82.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	6%	11%	7%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	295	362	517	493	583	684	726	1,069	1,254	1,904
Share Capital ⓘ	71	71	71	252	252	252	42	42	42	43
Reserves ⓘ	224	291	447	241	331	432	684	1,028	1,213	1,860
Debt +	123	60	34	368	438	416	848	636	768	498
Long Term Debt	113	45	1	365	418	340	768	545	547	449
Short Term Debt	9	15	33	2	20	75	80	92	221	50
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	27	18	33	36	47	73	88	110	184	186
Others Liabilities ⓘ	95	82	79	147	204	276	461	617	588	564
Total Liabilities ⓘ	540	522	663	1,044	1,273	1,449	2,124	2,432	2,794	3,151
Fixed Assets
Net Fixed Assets ⓘ +	364	398	347	295	440	1,102	1,068	1,804	1,767	2,238
Gross Block	408	497	498	499	688	1,424	1,475	2,320	2,406	2,953
Accumulated Depreciation	44	99	150	204	248	321	407	516	639	715
CWIP ⓘ	69	3	79	468	691	126	589	158	483	64
Investments ⓘ	0	29	71	0	0	0	0	21	21	97
Inventories	37	28	30	41	48	54	154	212	263	388
Trade Receivables	46	44	77	77	76	119	256	166	179	232
Cash Equivalents	1	0	5	129	0	1	25	15	7	22
Others Assets ⓘ	23	20	54	34	16	47	31	56	76	110
Total Assets ⓘ	540	522	663	1,044	1,273	1,449	2,124	2,432	2,794	3,151

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	123	138	225	261	165	229	284	626	398	441
PBT ⓘ	88	75	195	242	141	161	383	523	291	540
Adjustment ⓘ	64	73	61	70	56	103	130	170	196	178
Changes in Working Capital ⓘ	-11	10	7	8	-4	-6	-169	41	-38	-167
Tax Paid ⓘ	-17	-20	-38	-59	-28	-29	-60	-107	-51	-110
Cash Flow From Investing Activity ⓘ +	-40	-63	-167	-217	-363	-197	-455	-437	-401	-262
Capex	-59	-35	-122	-303	-369	-197	-456	-416	-398	-186
Net Investments	18	-28	-112	82	2	-0	1	-1	-3	-75
Others ⓘ	0	0	68	4	4	0	0	-20	0	0
Cash Flow From Financing Activity ⓘ +	-83	-76	-58	85	69	-32	195	-200	-8	-164
Net Proceeds from Shares ⓘ	0	0	0	15	0	0	0	0	0	333
Net Proceeds from Borrowing ⓘ	-70	0	0	350	110	-47	239	-64	17	-112
Interest Paid ⓘ	-22	-14	-9	-9	-37	-40	-48	-60	-72	-66
Dividend Paid ⓘ	0	0	0	-3	0	0	0	-10	-10	-32
Others ⓘ	9	-62	-49	-268	-4	54	4	-65	58	-288
Net Cash Flow ⓘ	-0	-0	-0	129	-129	1	24	-11	-11	15

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	26.27	20.26	35.37	45.75	34.23	23.85	42.16	39.37	16.85	22.59
ROCE (%)	22.27	18.45	37.92	36.88	15.9	16.74	29.4	32.2	17.5	25.22
Asset Turnover Ratio	0.83	0.84	1.04	0.85	0.55	0.63	0.9	1.02	0.77	0.91
PAT to CFO Conversion(x)	1.84	2.06	1.45	1.43	1.47	2.27	1.12	1.77	2.03	1.24
Working Capital Days
Receivable Days	36	37	36	39	44	42	43	33	31	28
Inventory Days	23	27	17	18	26	22	24	29	43	44
Payable Days	54	48	39	50	55	57	39	32	51	50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Epigral Ltd FAQs

The current trading price of Epigral on 17-Apr-2026 16:59 is ₹1,200.8.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Apr-2026 the market cap of Epigral stood at ₹5,180.2 Cr

The latest P/E ratio of Epigral as of 16-Apr-2026 is 15.34.

The latest P/B ratio of Epigral as of 16-Apr-2026 is 2.42.

The 52-week high of Epigral is ₹2,114.3 and the 52-week low is ₹806.2.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Epigral is ₹2,419 ( Cr.) .

About Epigral Ltd

Meghmani Finechem Limited (MFL) is a Public Company limited by shares domiciled in India, incorporated under the provisions of Companies Act, 1956. The registered office of the company is located at GIDC Industrial Estate, Dahej, Tal. Vagara, Dist. Bharuch, Gujarat.

It is an ISO 9001 and ISO 14001-certified company founded in 2007 and recognised as one of the leading producers of chlor alkali and its Derivatives with backward and forward integration facilities. The Company meets the global essential chemicals demand with responsible care and with large-scale growth, while committing to quality and environment integrity.

MFL works out of an advanced automated production facility, which is equipped to address international standards in the manufacture of Caustic Soda, Caustic Potash, Chlorine, Hydrogen, Chloromethanes and Hydrogen Peroxide. The Company aims to service domestic as well as export markets, contributing towards the ‘Make in India’ initiative.

Business area of the company

The Company is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives. The Company is also engaged in Trading of Agrochemical products.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Epigral Ltd (EPIGRAL) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Epigral Share Price